Portfolio

Xeptiva Therapeutics develops innovative immunotherapies for chronic inflammation in pets, focusing on enhancing their healthspan with first-in-class therapeutic vaccines.

Biomakers transforms genomic data into therapeutic decisions, specializing in personalized treatments through genomic testing and partnerships for access to complex drugs, operating in Latin America.

Through science and bioengineering, Harmony is disrupting the infant nutrition industry, by developing formulas to replace cow's milk with easy, healthy, ethical and sustainable solutions.

ISA is a digital health services platform that simplifies the delivery of healthcare solutions to patients wherever they are.

Production of sea pea (lemna) protein concentrate using the existing infrastructure of aquaculture farms in a scalable manner.

A non-invasive electro-acoustic patch that monitors lung function in patients with COPD, asthma and Covid.

A safe, non-invasive treatment for patients with advanced cancer that consists of applying specific electromagnetic frequencies to improve the results of standard oncology treatment. 

Integrates artificial intelligence algorithms, low-cost genomic sequencing and remote medicine to detect cardiovascular diseases anywhere in the world.

Medical application that corrects sleep problems through cognitive and behavioral treatments prescribed by physicians and reimbursed by the healthcare system. Listed on Nasdaq North.